Abstract
Stem cell factor (SCF), a hematopoietic growth factor, is the ligand of the tyrosine kinase receptor encoded by the c-kit proto-oncogene. Beside the important role of this receptor-ligand complex in hematopoiesis, gametogenesis and melanogenesis, SCF and its receptor have been shown to be expressed in the brain. We have studied the expression of SCF and c-kit in 20 human malignant glioma cell lines at the mRNA as well as at the protein level. In addition, recombinant human (rh) SCF was tested in [3H]thymidine uptake assays for a mitogenic effect on these cells. SCF and c-Kit proteins were detected in the cytoplasm of glioma cells by alkaline phoshatase-monoclonal anti-alkaline phosphatase immunostaining and Western blot analysis. However, neither SCF nor c-Kit were seen on the cell surface by flow cytometry. Furthermore, none of the proliferation assays showed a mitogenic effect for exogenously added rhSCF. Blocking studies using an anti-SCF antibody failed to demonstrate modulating effects on the growth of selected cell lines. These results suggest that SCF and c-Kit may mediate non-proliferative signals or may employ intracellular mechanisms for autocrine growth regulation of glioma cells.
Similar content being viewed by others
References
Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpell SD, Cosman D, Williams DE (1990) Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane-bound and soluble forms. Cell 63: 235–243
Aye MT, Hashemi S, Leclair B, Zeibdawi A, Trudel E, Halpenny M, Fuller V, Cheng G (1992) Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp Hematol 20: 529–527
Bejcek BE, Li DY, Deuel TF (1989) Transformation by the v-sis occurs by an internal autoactivation mechanism. Science 245: 1496–1499
Berdel WE, Danhauser-Riedl S, Doll M, Herrmann F (1990) Effect of hematopoietic growth factors on the growth of non-hematopoietic tumor cell lines. In: Mertelsmann R, Herrmann F (eds) Hematopoietic growth factors in clinical applications. Dekker, New York, pp 339–362
Berdel WE, De Vos S, Maurer J, Oberberg D, Marschall Z von, Schroeder JK, Li J, Ludwig WD, Kreuser ED, Thiel E, Herrmann F (1992) Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52: 3498–3502
Betsholtz C, Westermark B, Ek B, Heldin C-H (1984) Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation. Cell 39: 447–457
Chirgwin JM, Przybyla AE, Macdonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299
Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase. J Histochem Cytochem 32: 219–229
Dunbar CE, Browder TM, Abrams JS, Nienhuis AW (1989) COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science 245: 1493–1496
Flanagan JG, Chan DC, Leder P (1991) Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sl d mutant. Cell 64: 1025–1035
Hadam MR (1985) Flow cytometry and surface marker phenotyping using monoclonal antibodies: a combined approach to precisely define the state of the immune system. In: Gillisen G, Theurer KE (eds) New aspects in physiological antitumor substances, Karger, Basel, pp120–146
Hannink M, Donoghue DJ (1988) Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface. J Cell Biol 107: 287–298
Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T (1991) Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6: 2291–2296
Jennings MT, Jennings VDL, Asadourian LLH, Ebrahim SAD, Klein CE, Old LJ (1989) Antigenic phenotypes of cultured malignant astrocytomas: identification of lineage-consistent, lineage-independent and putative tumor-restricted antigenic expression. J Neurol Sci 89: 79–92
Kawasaki ES (1990) Amplification of RNA. In: Innis MA, Gelfand DH, Shinsky JJ, White TJ (eds) PCR protocols. Academic Press, San Diego, p 21
Keating MT, Williams LT (1988) Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 239: 914–916
Keshet E, Lyman SD, Williams DE, Anderson DM, Jenkins NA, Copeland NG. Parada LF (1991) Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J 10: 2425–2435
Keski-Oja J, Lyons RM, Moses HL (1987) Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-β. Cancer Res 47: 6451–6458
Lassam N, Bickford S (1992) Loss of c-kit expression in cultured melanoma cells. Oncogene 7: 51–56
Lerner NB, Nocka KH, Cole SR, Qiu F, Strife A, Ashman LK, Besmer P (1991) Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77: 1876–1883
Matsui Y, Zsebo KM, Hogan BLM (1990) Embryonic expression of a hematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 347: 667–671
Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A (1992) Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52: 6139–6143
Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A (1992) Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer 52: 713–717
Natali PG, Nicotra MR, Winkler AB, Cavalieri A, Bigotti A, Ullrich A (1992) Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 52: 197–201
Nister M, Libermann T, Betsholz C, Petterson M, Claesson-Welsh L, Heldin C-H, Schlessinger J, Westermark B (1988) Expression of messenger mRNA for platelet-derived growth factor and transforming growth factor alpha and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910–3918
Pietsch T (1993) Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia. Nouv Rev Fr Hematol 35: 285–286
Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo KM, Welte K (1992) Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 80: 1199–1206
Rosenthal A, Lingquist PB, Bringman RS, Goeddel DV, Derynck R (1986) Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell 46: 301–309
Russel ES (1979) Hereditary anemias of the mouse. A review for geneticists. Adv Genet 20: 357–459
Sekido Y, Obata Y, Ueda R, Hida T, Suyuma M, Shimakata K, Ariyoshi Y, Takahashi T (1991) Preferential expression of c-kit proto-oncogene transcripts in small-cell lung cancer. Cancer Res 51: 2416–2419
Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A, Slamon DJ (1991) Expression of the hst-1 and c-kit proto-oncogenes in human testicular germ cell tumors. Cancer Res, 51: 1811–1816
Takeda H, Yoshiki A, Nishikawa S-I, Nishikawa S, Kunisada T, Sakakura T, Amanuma H, Kusakabe M (1992) Expression of c-kit, a proto-oncogene of the murine W locus, in cerebella of normal and neurological mutant mice: immunohistochemical and in situ hybridization analysis. Differentiation 31: 121–127
Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke L, Ullrich A (1987) Human proto-oncogene c-kit, a new cell surface kinase for an unidentified ligand. EMBO J 6: 3341–3351
Zsebo KM, Martin FH, Suggs SV, Wypych J, Lu HS, McNiece IK, Medlock E, Morris CF, Sachdev RK, Tung W, Birkett NC, Smith KA, Yuschenkoff VN, Mendiaz EA, Jacobson FW, Langley KE (1990) Biological characterization of a unique early acting hematopoietic growth factor. Exp Hematol 18: 703.
Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Satyagal VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE (1990) Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver conditioned medium. Cell 63: 195–205
Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobson FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV (1990) Stem cell factor (SCF) is encoded by the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213–224
Zülch KJ (1986) Brain tumors. Their biology and pathology. Springer, Berlin Heidelberg New York, pp 1–26
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stanulla, M., Welte, K., Hadam, M.R. et al. Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines. Acta Neuropathol 89, 158–165 (1995). https://doi.org/10.1007/BF00296360
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00296360